
Veno-venous Extracorporeal Membrane Oxygenation for Respiratory Failure in COVID-19 Patients
Author(s) -
Asishana Osho,
Philicia Moonsamy,
Kathryn A. Hibbert,
Kenneth Shelton,
John M. Trahanas,
Rizwan Attia,
Jordan P. Bloom,
Michael T. Onwugbufor,
David A. D’Alessandro,
Mauricio A. Villavicencio,
Thoralf M. Sundt,
Jerome Crowley,
Yuval Raz,
Masaki Funamoto
Publication year - 2020
Publication title -
annals of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.153
H-Index - 309
eISSN - 1528-1140
pISSN - 0003-4932
DOI - 10.1097/sla.0000000000004084
Subject(s) - medicine , extracorporeal membrane oxygenation , interquartile range , mechanical ventilation , ards , intensive care unit , intensive care medicine , respiratory failure , intensive care , emergency medicine , surgery , anesthesia , lung
VV ECMO can be utilized as an advanced therapy in select patients with COVID-19 respiratory failure refractory to traditional critical care management and optimal mechanical ventilation. Anticipating a need for such therapies during the pandemic, our center created a targeted protocol for ECMO therapy in COVID-19 patients that allows us to provide this life-saving therapy to our sickest patients without overburdening already stretched resources or excessively exposing healthcare staff to infection risk.